Dual-center retrospective study on the efficacy and safety of neoadjuvant therapy in the patients with resectable pancreatic cancer
Not Applicable
Recruiting
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000052876
- Lead Sponsor
- School of Medicine, Wakayama Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 550
Inclusion Criteria
Not provided
Exclusion Criteria
1. diagnosis of borderline or unresectable pancreatic cancer according to NCCN guideline (Ver.2. 2021) 2. conversion surgery in the patients with unresectable pancreatic cancer
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of overall survival between upfront surgery and neoadjuvant therapy in the patients with resectable pancreatic cancer
- Secondary Outcome Measures
Name Time Method 1. detection of prognostic factor in the patients with resectable pancreatic cancer 2. comparison of recurrence free survival between upfront surgery and neoadjuvant therapy 3. comparison of surgical outcome between upfront surgery and neoadjuvant therapy 4. comparison of morbidity and induction of the adjuvant therapy between upfront surgery and neoadjuvant therapy 5. detection of the unresectable factor in the patients received neoadjuvanvt therapy with resectable pancreatic cancer